Verastem, Inc. (VSTM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6050+0.0350 (+1.36%)
As of 2:01PM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 2.5700 |
| Open | 2.5600 |
| Bid | 2.6000 x 4000 |
| Ask | 2.6100 x 4000 |
| Day's Range | 2.5400 - 2.6200 |
| 52 Week Range | 1.0800 - 4.6700 |
| Volume | 684,072 |
| Avg. Volume | 3,039,261 |
| Market Cap | 447.19M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4420 |
| Earnings Date | May 05, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.50 |
- Simply Wall St.
How Much Of Verastem, Inc. (NASDAQ:VSTM) Do Institutions Own?
A look at the shareholders of Verastem, Inc. ( NASDAQ:VSTM ) can tell us which group is most powerful. Institutions...
- Insider Monkey
10 Best Pharma Stocks to Buy Now
In this article we will take a look at the 10 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical industry’s outlook for 2021 and some of the major growth catalysts for pharma stocks and go directly to 5 Best Pharma Stocks to Buy Now. As value stocks begin […]
- Business Wire
Verastem Oncology Reports Fourth Quarter and Full Year 2020 Financial Results, Clinical Updates and Guidance for Key Milestones in 2021 and 1H 2022
Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today reported financial results for the three months and full year ending December 31, 2020, and highlighted its key corporate objectives for 2021 and early 2022.
© 2021 Verizon Media. All rights reserved.
